Katrin Andreasson is the senior author of a study that identifies a particular set of immune cells as a key driver of mental aging.
Steve Fisch
Scientists have identified a key factor in mental aging and shown that it might be prevented or reversed by fixing a glitch in the immune system’s front-line soldiers.
Suppose Smokey Bear were to lose it and start setting forest fires instead of putting them out. That roughly describes the behavior of certain cells of our immune system that become increasingly irascible as we grow older. Instead of stamping out embers, they stoke the flames of chronic inflammation.
Biologists have long theorized that reducing this inflammation could slow the aging process and delay the onset of age-associated conditions, such as heart disease, Alzheimer’s disease, cancer and frailty, and perhaps even forestall the gradual loss of mental acuity that happens to nearly everyone.
Yet the question of what, exactly, causes particular cells of the immune system to kick into inflammatory overdrive has lacked a definitive answer.
Now, Stanford Medicine researchers think they have one. If their findings in old mice and in human cell cultures apply to actual humans, they could presage the pharmaceutically managed recovery of older people’s mental abilities.
In a study published Jan. 21 in Nature, the investigators pin the blame on a set of immune cells called myeloid cells. Katrin Andreasson, MD, professor of neurology and neurological sciences, is the study’s senior author. Its lead author is MD-PhD student Paras Minhas.
Myeloid cells, which are found in the brain, the circulatory system and the body’s peripheral tissues, are part soldier and part park ranger. When not fighting off infectious intruders, they keep busy cleaning up debris, such as dead cells and clumps of aggregated proteins; provide nutrient snacks to other cells; and serve as sentinels watching for signs of invading pathogens.
But as we age, myeloid cells begin neglecting their normal, health-protecting functions and adopting an agenda of endless warfare with a nonexistent enemy, inflicting collateral damage to innocent tissues in the process.
Effective blockade
In the study, blocking the interaction of a particular hormone and a receptor that abounds on myeloid cells was enough to restore the youthful metabolism and placid temperament of mouse and human myeloid cells in a dish and in living mice. This blockade also reversed age-related mental decline in older mice, restoring their recall and navigation skills to those exhibited by young mice.
“If you adjust the immune system, you can de-age the brain,” Andreasson said. Her team’s experiments in human cells suggest that similar rejuvenation may be possible in people, she said.
Myeloid cells are the body’s main source of PGE2, a hormone that belongs to the family known as prostaglandins. PGE2 does many different things in the body — some good, some not always so good — for example, promoting inflammation. What PGE2 does depends on which cells, and which of several different varieties of receptor on those cells’ surfaces, the hormone lands on.
One receptor type for PGE2 is EP2. This receptor is found on immune cells and is especially abundant on myeloid cells. It initiates inflammatory activity inside the cells after binding to PGE2.
Andreasson’s team cultured macrophages, a class of myeloid cells situated in tissues throughout the body, from people older than 65 and compared them with macrophages from people younger than 35. They also looked at macrophages of young versus old mice.
‘A double-whammy’
Older mouse and human macrophages, they observed, not only produced much more PGE2 than younger ones but also had far greater numbers of EP2 on their surfaces. Andreasson and her colleagues also confirmed significant increases of PGE2 levels in the blood and brains of old mice.
“It’s a double-whammy — a positive feedback loop,” Andreasson said. The resulting exponential increase in PGE2-EP2 binding amps up intracellular processes associated with inflammation in the myeloid cells.
The investigators showed, in both human and mouse myeloid cells, how this inflammatory hyperdrive sets in: The vastly increased PGE2-EP2 binding in myeloid cells of older individuals alters energy production within these cells by rerouting glucose — which fuels energy production in the cell — from consumption to storage.
The researchers found that myeloid cells undergo an increasing propensity, driven by age-associated increased PGE2-EP2 binding, to hoard glucose by converting this energy source into long glucose chains called glycogen (the animal equivalent of starch) instead of “spending” it on energy production. That hoarding, and the cells’ subsequent chronically energy-depleted state, drives them into an inflammatory rage, wreaking havoc on aging tissues.
“This powerful pathway drives aging,” she said. “And it can be downshifted.”
The Stanford scientists showed this by blocking the hormone-receptor reaction on myeloid-cell surfaces in the mice. They gave mice either of two experimental compounds known to interfere with PGE2-EP2 binding in the animals. They also incubated cultured mouse and human macrophages with these substances. Doing so caused old myeloid cells to metabolize glucose just as young myeloid cells do, reversing the old cells’ inflammatory character.
More striking, the compounds reversed mice’s age-related cognitive decline. Older mice who received them performed as well on tests of recall and spatial navigation as young adult mice.
One of the two compounds the Stanford scientists used was effective even though it doesn’t penetrate the blood-brain barrier. This suggests, Andreasson said, that even resetting myeloid cells outside the brain can achieve profound effects on what goes on inside the brain.
Neither compound is approved for human use, she noted, and it’s possible they have toxic side effects, although none were observed in the mice. They provide a road map for drug makers to develop a compound that can be given to people.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Age-related cognitive decline
- Diets rich in protein and anti-inflammatory foods may guard against cognitive decline
Researchers evaluate the effects of a protein-enriched and anti-inflammatory diets on cognitive impairment in older adults in China.
- Maintain Your Brain Fitness as You Age by Prioritizing These 6 Things
Exercising your mind is just as important as your body. These are the top six things you should practice as you age to help keep your mind sharp.
- Anti-Inflammatory Diet May Lead to 21% Lower Risk of Cognitive Impairment, According to New Study
While many factors influence age-related cognitive impairment, the CDC estimates the prevalence at 11.7% in adults aged 65 years and older, and 10.8% among adults 45-64 years of age. Some signs of ...
- Neuroscientists Reveal Secret of Superagers' Excellent Memories
White matter, which connects different regions of the brain, appears to retain better structure in superagers than in older people with memory decline.
- Does 'Brain Training' Really Improve Cognition and Forestall Cognitive Decline?
Some companies claimed that engaging in "brain games" can improve cognition or stave off cognitive decline. What's the evidence and do crosswords and Sudoku count?
Go deeper with Google Headlines on:
Age-related cognitive decline
[google_news title=”” keyword=”age-related cognitive decline” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Inflammatory hyperdrive
- Nonsteroidal Anti-Inflammatory Drugs and Hypertension
Nonsteroidal anti-inflammatory drugs are among the most widely prescribed medications. Their effect on blood pressure has been monitored, and many small studies have determined a potential ...
- The Prevalence of Elevated Serum C-Reactive Protein Levels in Inflammatory and Noninflammatory Thyroid Disease
This study was intended to determine whether CRP levels could differentiate between inflammatory and noninflammatory thyroid conditions, especially between type II inflammatory amiodarone-induced ...
- Scientists discover the cellular functions of a family of proteins integral to inflammatory diseases
These cells are known for producing interleukin-17 (IL-17), a highly inflammatory cytokine associated with a spectrum of disorders, including IBD, multiple sclerosis, and rheumatoid arthritis.
- "An Anti-Inflammatory Diet Is A Good Idea For Anyone To Follow" — Doctors Shared The Food And Drinks That Could Be Causing Your Joints To Ache
One common type is rheumatoid arthritis, which affects an estimated 1.3 million people in the U.S. Rheumatoid arthritis is a chronic inflammatory disorder that can cause joint pain. The earliest ...
- Driving Quality to New Heights: Galaxy Semiconductor’s Hyperdrive Predictive Quality System
Hyperdrive Predictive Quality System is a streaming real-time monitoring application that runs on a cluster of servers. By using the latest and greatest IT technology, a Kubernetes deployment ...
Go deeper with Google Headlines on:
Inflammatory hyperdrive
[google_news title=”” keyword=”inflammatory hyperdrive” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]